Agenus Inc (NASDAQ: AGEN), a clinical-stage immune-oncology company developing innovative therapies for treatment of cancer, announced the grant of a Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [CTLA-4] for the treatment of patients with relapsed or refractory metastatic cervical cancer. [caption...
Education Technology is a burgeoning industry owing to a rise in internet penetration and use of smart phones. There is a growing acceptance of e-learning and many governments are providing impetus to e-learning initiatives. The advancements witnessed in the smart phone technology have revolutionized the...
Sonasoft (OTCQB: SSFT), a pioneer in the AI powered data management solutions space, has launched AURA , the world’s first AI powered people support engine, which can work with pre-existing systems to provide unmatched insights and assistance. The platform can supplement the capabilities of tools...
Conformis Inc (NASDAQ: CFMS), a medical technology company dealing in Knee and Joint replacements, has announced the clearance of its next generation Conformis Hip System by the FDA. The Company’s leading-edge patient-specific arthroplasty joint replacement implants, moulded to suit each patient’s unique anatomy, are developed...
Forewarn, Red Violet Company (NASDAQ: RDVT), a leading consumer insight solution provider, announced that it has entered into a partnership agreement with the Central Illinois Board of REALTORS®, to make its cutting-edge risk assessment and customer due diligence technology available to over 500+ REALTOR® members...
Kandi Technologies Group Inc (NASDAQ: KNDI), a Company engaged in the development and manufacturing of vehicular products, announced that it has successfully executed a purchase framework agreement with DGL Group Inc, Wal-Mart’s largest supplier of electric self-balancing scooters under intelligent transportation product category. The agreement...
Adverum Biotechnologies (NASDAQ: ADVM), a clinical-stage Company focused on developing therapeutics for ocular and rare diseases through gene therapy, released additional clinical data from its ongoing OPTIC phase 1 clinical trial of ADVM-022. ADVM-022, the Company’s lead ocular candidate, is an adeno- associated virus (AAV)....
The shares of Curaleaf (OTCQX: CURLF) surged by almost 15% since the news of its acquisition of Cura Partners, the owner of Select brand, in an all-stock deal valued at C$1.27 billion or US$948.8 million became public. The deal will offer both the companies the ability to diversify and leverage...
The Muscular Dystrophy Association describes Duchenne Muscular Dystrophy (DMD) as a fatal, X-linked genetic neuromuscular disorder that leads to progressive, irreversible loss of muscle function, including the heart and lungs. It has an X-linked recessive inheritance pattern and is acquired by a “Carrier” mother. Globally, 1 in...
